Enforcement Report - Week of May 29, 2024
Enforcement Report - Week of August 25, 2021
Gland Pharma's Generic Haloperidol Decanoate Receives Approval in US
Zydus Healthcare`s Generic Haloperidol Decanoate Receives Approval in US
Bio-Rad Laboratories, Inc., a life science research and clinical diagnostic products company, has joined the European Molecular Biology Laboratory (EMBL) Corporate Partnership Program to help expand EMBL’s portfolio of scientific training courses designed for scientists.
Somerset Theraps LLC’s Generic Haloperidol Decanoate Receives Approval In The US
Gland Pharma’s Generic Haloperidol Decanoate Receives Approval In US
Mylan Institutional LLC, Ongoing Class II recall of Haloperidol Decanoate Injection, 50 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-410-00) packaged in cartons of ten (NDC 67457-410-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 because of Lack of Assurance of Sterility; due to leaking vials
Mylan Institutional LLC, Ongoing Class II recall of Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-409-00) packaged in cartons of five (NDC 67457-409-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 because of Lack of Assurance of Sterility; due to leaking vials